Frank X. Liu - Concepedia

Author

Frank X. Liu

Pfizer (United States)ORCID

Also Known As

Frank X Liu, Frank X. Liu

Publications

265

Citations

H-Index

Concepts

All Affiliations

Pfizer (United States)Ono Pharmaceutical (United States)Texas Oncology McKesson (United States)Epi-Q (United States)

About

Frank X. Liu is an author at Pfizer (United States) specializing in oncology, outcomes research, and surgical oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Health Sciences	1	1	12
2	Medicine	1	1	12
3	Surgical Oncology	1	1	12
4	Cancer Therapeutics	1	1	12
5	Clinical Trials	1	1	12

Frank X. Liu

Publications

188

Citations

H-Index

Page 1

	Year	Citations
Maximum Torque and Momentum Envelopes for Reaction Wheel Arrays F. Landis Markley, R. G. Reynolds, Frank X. Liu, Journal of Guidance Control and Dynamics	2010	68
The Impact of Adverse Events on Health Care Resource Utilization, Costs, and Mortality Among Patients Treated with Immune Checkpoint Inhibitors Saby George, Elizabeth J. Bell, Ying Zheng, The Oncologist	2021	29
Real-World Clinical Outcomes with First-Line Avelumab in Locally Advanced/metastatic Merkel Cell Carcinoma in the USA: SPEAR-Merkel C. Lance Cowey, Frank X. Liu, Ruth Kim, Future Oncology	2021	20
Experience of establishing an acute geriatric outreach service versus subacute service to nursing homes Daniel Kam Yin Chan, Frank X. Liu, Deni Irwanto, Internal Medicine Journal	2018	16
Avelumab first-line maintenance therapy for locally advanced/metastatic urothelial carcinoma: Results from the real-world US PATRIOT-II study. Petros Grivas, Pedro C. Barata, Helen Moon, Journal of Clinical Oncology Surgical OncologyAdvanced/metastatic Urothelial CarcinomaCancer ManagementGynecology OncologyOncology	2024	12
Avelumab First-Line Maintenance for Locally Advanced or Metastatic Urothelial Carcinoma: Results From the Real-World US PATRIOT-II Study Petros Grivas, Pedro Barata, Helen Moon, Clinical Genitourinary Cancer	2024	12
Clinical and Economic Outcomes in Patients With Metastatic Urothelial Carcinoma Receiving First-Line Systemic Treatment (the IMPACT UC I Study) Mehmet Asım Bilen, Scott B. Robinson, Amy Schroeder, The Oncologist	2023	11
<scp>Real-World</scp>Clinical Outcomes in Patients with Locally Advanced or Metastatic Merkel Cell Carcinoma Treated in U.S. Oncology Clinical Practices: Results from<scp>SPEAR-Merkel</scp> Abhijeet Bhanegaonkar, Frank X. Liu, Marley Boyd, The Oncologist	2021	10
A multiplexable microfluidic injector for versatile encoding of droplets Johnson Q. Cui, Bin‐Bin Cui, Frank X. Liu, Sensors and Actuators B Chemical	2022	10

Page 1